510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1537-2018Class II

Modular Head Component, Biomet Hip System; Item No. 163669, Hip Joint, metal/polymer semi-constrained...

Zimmer GmbH / initiated 2018-04-02 / Terminated / root cause: manufacturing process

Zimmer Biomet, Inc. began a recall of Modular Head Component, Biomet Hip System; Item No. 163669, Hip Joint, metal/polymer semi-constrained cemented prosthesis The device is used in treatment of... on . FDA classified it as Class II and gives the reason as "Two lots of different sized modular heads potentially commingled. Risks include delay in surgery and dislocation due to use of an incorrect sized head". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1537-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Zimmer GmbH
Product
Modular Head Component, Biomet Hip System; Item No. 163669, Hip Joint, metal/polymer semi-constrained cemented prosthesis The device is used in treatment of patients who need total hip arthroplasty, and consists of modular components and corresponding instruments.
Product code
JDI Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented
Reason for recall
Two lots of different sized modular heads potentially commingled. Risks include delay in surgery and dislocation due to use of an incorrect sized head.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
The firm, Zimmer Biomet, sent an "URGENT MEDICAL DEVICE RECALL" letter dated 4/2/2018 to its customers. The letter described the product, problem and actions to be taken. Distributors will be notified of the recall via email. Hospital risk managers and distributors with product will be notified via courier. The distributor letter includes instructions to locate and remove the product in their territory, identify hospitals who have previously used the product; return on-hand product to the recalling firm and ensure all products are accounted for. The letter for hospital risk managers instruct the risk managers to assist the recalling firm's sales reps with quarantine of the product; to review notification and ensure affected personnel are aware of the contents; and complete and return the Certificate of Acknowledgement form to [email protected], even if you do not have product, and retain a copy. Customers with questions are directed to call customer service at 574-371-3071 between 8AM-5PM EST, Monday through Friday. Alternatively, questions may be emailed to [email protected].
Quantity in commerce
30
Distribution
Worldwide Distribution: US (nationwide) in states of: AL, AR, FL, GA, IN, KY, LA, MO, MS, OH, OK, TX, and VA; and countries of: Canada, Costa Rica and Chile.
Product codes and lots
lot 276760

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1537-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1537-2018Class IITerminatedVoluntary: Firm initiated
Z-1538-2018Class IITerminatedVoluntary: Firm initiated